Check-Cap and GE Healthcare announced the companies have achieved the initial milestone in their collaboration to develop high-volume, X-ray capsule manufacturing capabilities. X-ray sources produced at GE Healthcare using a manufacturing method passed all tests required to ensure compliance with C-Scan system specifications.
"We are very excited to have achieved success in the first critical phase of our collaboration with GE Healthcare, where we demonstrated the capability of our process to manufacture X-ray sources for the C-Scan system," Bill Densel, CEO of Check-Cap said. "We look forward to moving ahead with the development and validation of scalable production and integration processes that can provide capsules for future U.S. clinical trials and commercialization."
Colorectal cancer is the second leading cause of cancer death in the U.S., with an estimated 135,000 diagnoses and 50,000 deaths in 2017. Nearly one-third of the recommended adult population has never been screened. The C-Scan system is designed to improve the patient experience with screening by eliminating many unattractive requirements, such as bowel preparation, fasting, and sedation.
"The results of this critical phase of the collaboration are incredibly exciting for patients and the future prevention of colorectal cancer," Emmanuel Ligner, General Manager of Core Imaging for GE Healthcare Life Sciences said. "GE Healthcare will continue its collaboration with Check-Cap using our expertise in radiopharmaceutical and device manufacturing to bring the C-Scan system to clinicians and patients."